Case Type: Mergers & Acquisitions

LAVA Therapeutics N.V. (NASDAQ: LVTX) related to its sale to XOMA Royalty Corporation. Under the terms of the proposed transaction, XOMA Royalty will acquire LAVA for $1.16 in cash per share, plus up to $0.08 per share and a non-transferable contingent value right per share representing the right to receive 75% of the net proceeds … Read more

HilleVax, Inc. (NASDAQ: HLVX) related to its sale to XOMA Royalty Corporation. Under the terms of the proposed transaction, HilleVax stockholders will receive $1.95 in cash per share, plus one non-transferable contingent value right, representing the right to receive additional payments under certain post-closing financial conditions.

Performant Healthcare, Inc. (NASDAQ: PHLT) related to its sale to Machinify. Under the terms of the proposed transaction, Performant shareholders will receive $7.75 in cash per share.

CyberArk Software Ltd. (NASDAQ: CYBR) related to its sale to Palo Alto Networks for $45.00 in cash and 2.2005 shares of Palo Alto common stock for each CyberArk share.

CoreCard Corporation (NYSE: CCRD) related to its sale to Euronet Worldwide for an exchange ratio between 0.2783 and 0.3142 of Euronet common stock per share of CoreCard.

Norfolk Southern Corporation (NYSE: NSC) related to its sale to Union Pacific Corporation for 1.0 Union common stock and $88.82 in cash for each share of Norfolk.

DURECT Corporation (NASDAQ: DRRX) related to its sale to Bausch Health Companies Inc. for $1.75 per share in cash.

Chart Industries, Inc. (NYSE: GTLS) related to its sale to Baker Hughes Co. for $210.00 per share in cash.

Pinnacle Financial Partners (NASDAQ: PNFP) related to its merger with Synovus Financial Corp. Upon the terms of the proposed transaction, the shares of Synovus and Pinnacle shareholders will be converted into shares of a new Pinnacle parent company based on a fixed exchange ratio of 0.5237 Synovus shares per Pinnacle share. Upon closing of the … Read more

Synovus Financial Corp. (NYSE: SNV) related to its merger with Pinnacle Financial Partner. Upon the terms of the proposed transaction, the shares of Synovus and Pinnacle shareholders will be converted into shares of a new Pinnacle parent company based on a fixed exchange ratio of 0.5237 Synovus shares per Pinnacle share. Upon closing of the … Read more